Macro Group Pharmaceutical SAE EGX:MCRO:
MACRO GROUP PHARMACEUTICAL FY CONSOL PROFIT ATTRIBUTABLE EGP 115.7 MILLION
MACRO GROUP PHARMACEUTICAL FY CONSOL NET SALES EGP 894.5 MILLION
Macro Group Pharmaceutical FY Consol Profit EGP 115.7 Mln
Macro Group Pharmaceutical S.A.E. on 6ix
Story so far
Earlier from Macro Group Pharmaceutical S.A.E
- MACRO Group Pharmaceutical 9-Month Consol Loss EGP 66.1 Million
- Macro Group Pharmaceutical Shareholders Approve Authorized Capital Increase To EGP 3 Bln
Later from Macro Group Pharmaceutical S.A.E
- Macro Group Pharmaceuticals -Macro Capital (MCRO.CA) - Board of Directors Decisions
- Release from Macro Group Pharmaceuticals -Macro Capital (MCRO.CA) Regarding the Company's Financial Results (in English)
- Release from Macro Group Pharmaceuticals -Macro Capital (MCRO.CA) Regarding a Disclosure Form
Follow Macro Group Pharmaceutical S.A.E into a list and get an email when it puts out news.
Follow Macro Group Pharmaceutical S.A.E